| 1 |
Nathan Stewart |
Trijicon |
4 |
| 2 |
Jay Copeland Strum |
G1 Therapeutics |
3 |
| 2 |
Mark S. Wilson |
Biomerieux |
3 |
| 2 |
Wilson Christopher Lamb |
Rai Strategic Holdings |
3 |
| #5 |
W. Andrew Grubbs |
Intuitive Surgical |
2 |
| #5 |
Aaron Hummel |
Pairwise Plants Services |
2 |
| #5 |
Kenneth R. Phares |
United Therapeutics |
2 |
| #5 |
James Richmond |
Cree |
2 |
| #9 |
Gina Renee Howard |
IBM |
1 |
| #9 |
John Martin Jans |
Tearscience |
1 |
| #9 |
Kristin Patricia Tully |
University Of North Carolina At Chapel Hill |
1 |
| #9 |
John Salmeron |
Syngenta Participations Ag |
1 |
| #9 |
Bruce Roberts |
Becton, Dickinson And |
1 |
| #9 |
Deirdre M. Hauser |
Metabolon |
1 |
| #9 |
Virginia Byers Kraus |
Duke University |
1 |
| #9 |
Thomas Christopher Broderick |
— |
1 |
| #9 |
Scott P. Runyon |
Research Triangle Institute |
1 |
| #9 |
Kimberly McHale |
Novan |
1 |
| #9 |
Leigh Peterson |
United Therapeutics |
1 |
| #9 |
Joshua Daniel Coyle |
Embecta |
1 |
| #9 |
Ulf Hakan Andre |
Cree |
1 |
| #9 |
Richard D. Cato |
Fujifilm Healthcare Americas |
1 |
| #9 |
John Malcolm Mitchell |
Research Triangle Institute |
1 |
| #9 |
Matthew J. Kostura |
Vtv Therapeutics |
1 |
| #9 |
David Green |
IBM |
1 |
| #9 |
Kaitlin Emily Harrington |
Thermochem Recovery International |
1 |
| #9 |
Doryan Algarra Jaimes |
— |
1 |
| #9 |
Keith William Anderson |
— |
1 |
| #9 |
Thomas S. Wallace |
IBM |
1 |